- Seven clinical trials across the world- More than 2/3 of STS patients recruited in the "act.in.sarc" Phase II/III trial- Phase I/II prostate cancer trial now recruiting in the U.S.

Paris, France and Cambridge, Massachusetts, USA, Nov 29, 2016 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage...